Recommendations for Successful Training on Methods of Delivery of Biologics for Cardiac Regeneration. A Report of the International Society for Cardiovascular Translational Research

Nabil Dib; Philippe Menasche; Jozef J. Bartunek; Andreas M. Zeiher; Andre Terzic; Nicolas A. Chronos; Timothy D. Henry; Nicholas S. Peters; Francisco Fernández-Avilés; Magdi Yacoub; Timothy A. Sanborn; Anthony DeMaria; Richard A. Schatz; Doris A. Taylor; Shmuel Fuchs; Silviu Itescu; Leslie W. Miller; Jonathan H. Dinsmore; George D. Dangas; Jeffrey J. Popma; Jennifer L. Hall; David R. Holmes

doi:10.1016/j.jcin.2009.12.013

Recommendations for Successful Training on Methods of Delivery of Biologics for Cardiac Regeneration. A Report of the International Society for Cardiovascular Translational Research

Nabil Dib, Philippe Menasche, Jozef J. Bartunek, Andreas M. Zeiher, Andre Terzic, Nicolas A. Chronos, Timothy D. Henry, Nicholas S. Peters, Francisco Fernández-Avilés, Magdi Yacoub, Timothy A. Sanborn, Anthony DeMaria, Richard A. Schatz, Doris A. Taylor, Shmuel Fuchs, Silviu Itescu, Leslie W. Miller, Jonathan H. Dinsmore, George D. Dangas, Jeffrey J. PopmaJennifer L. Hall, David R. Holmes

Medicine - Cardiology Division

Research output: Contribution to journal › Review article › peer-review

76 Scopus citations

Abstract

The field of myocardial regeneration (angiogenesis and myogenesis) might prove to play an important role in the future management of cardiovascular disease. Stem cells are currently undergoing testing in Phase I and Phase II clinical trials. Methods of delivery will affect the outcome of such therapies, perhaps significantly. This document provides suggested guidance in 4 methods of delivery: endocardial, intracoronary, coronary sinus, and epicardial.

Original language	English (US)
Pages (from-to)	265-275
Number of pages	11
Journal	JACC: Cardiovascular Interventions
Volume	3
Issue number	3
DOIs	https://doi.org/10.1016/j.jcin.2009.12.013
State	Published - Mar 2010

Bibliographical note

Funding Information:
Dr. Dib has received research grants from Cardiovascular Biotherapeutics and Angioblast Systems, Inc. ; and consultant fees from Biologics Delivery Systems, Inc. (Cordis Corporation), and Cardio3 Biosciences. Dr. Bartunek has received research grants from Cardio3 Biosciences . Dr. Zeiher is an advisor and co-founder of t2Cure. Dr. Peters has received research grants from CardioPolymers Inc. and Medtronic, Inc. ; is a consultant and honorarium recipient from CardioPolymers Inc., Ablation Frontiers Inc., AstraZeneca Inc., Sanofi Aventis Inc., Magnetecs Inc., Bard Inc., and Bioheart Inc.; and has intellectual property and stock in CardioPolymers Inc. Dr. Sanborn is on the Speakers' Bureau of Merck; and is a Chairman and on the Data Safety Monitoring Board of St. Jude Medical. Dr. DeMaria has received research grants from Lantheus , Acusphere , CV Therapeutics , Cardiovascular Biotherapeutics , Angioblast Systems, Inc. , Philips Medical Systems , and General Electric Medical Systems ; and has stock options in Cardionet. Dr. Schatz has a licensing agreement with Biologics Delivery Systems and Cordis Corporation; is on the Scientific Advisory Board and Data Safety Monitoring Board of Baxter; and is a Speaker for Cordis Corporation and Medtronic, Inc. Dr. Itescu is President and founder of Angioblast Systems, Inc. Dr. Miller has received a research grant from Thoratec Corp . Dr. Dangas is a consultant for and has received honoraria from Cordis Corporation; and is a speaker for Cordis Corporation, Medtronic, Inc, and Boston Scientific. Dr. Popma has received research grants from Abbott Vascular , Boston Scientific , Cordis , ev3 , and Medtronic, Inc. Dr. Hall is a consultant for Catholic Healthcare West; and has received grants NIH - R01HL081715A1 and NIH - 1R21DK078029-01 .

Keywords

catheter
injection
myocardial regeneration
stem cells
training

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access

10.1016/j.jcin.2009.12.013

OpenUrl availability

Full text

Cite this

Dib, N., Menasche, P., Bartunek, J. J., Zeiher, A. M., Terzic, A., Chronos, N. A., Henry, T. D., Peters, N. S., Fernández-Avilés, F., Yacoub, M., Sanborn, T. A., DeMaria, A., Schatz, R. A., Taylor, D. A., Fuchs, S., Itescu, S., Miller, L. W., Dinsmore, J. H., Dangas, G. D., ... Holmes, D. R. (2010). Recommendations for Successful Training on Methods of Delivery of Biologics for Cardiac Regeneration. A Report of the International Society for Cardiovascular Translational Research. JACC: Cardiovascular Interventions, 3(3), 265-275. https://doi.org/10.1016/j.jcin.2009.12.013

Recommendations for Successful Training on Methods of Delivery of Biologics for Cardiac Regeneration. A Report of the International Society for Cardiovascular Translational Research. / Dib, Nabil; Menasche, Philippe; Bartunek, Jozef J. et al.
In: JACC: Cardiovascular Interventions, Vol. 3, No. 3, 03.2010, p. 265-275.

Research output: Contribution to journal › Review article › peer-review

Dib, N, Menasche, P, Bartunek, JJ, Zeiher, AM, Terzic, A, Chronos, NA, Henry, TD, Peters, NS, Fernández-Avilés, F, Yacoub, M, Sanborn, TA, DeMaria, A, Schatz, RA, Taylor, DA, Fuchs, S, Itescu, S, Miller, LW, Dinsmore, JH, Dangas, GD, Popma, JJ, Hall, JL & Holmes, DR 2010, 'Recommendations for Successful Training on Methods of Delivery of Biologics for Cardiac Regeneration. A Report of the International Society for Cardiovascular Translational Research', JACC: Cardiovascular Interventions, vol. 3, no. 3, pp. 265-275. https://doi.org/10.1016/j.jcin.2009.12.013

@article{8daaea3d17fe4026831e39549eb22849,

title = "Recommendations for Successful Training on Methods of Delivery of Biologics for Cardiac Regeneration. A Report of the International Society for Cardiovascular Translational Research",

abstract = "The field of myocardial regeneration (angiogenesis and myogenesis) might prove to play an important role in the future management of cardiovascular disease. Stem cells are currently undergoing testing in Phase I and Phase II clinical trials. Methods of delivery will affect the outcome of such therapies, perhaps significantly. This document provides suggested guidance in 4 methods of delivery: endocardial, intracoronary, coronary sinus, and epicardial.",

keywords = "catheter, injection, myocardial regeneration, stem cells, training",

author = "Nabil Dib and Philippe Menasche and Bartunek, {Jozef J.} and Zeiher, {Andreas M.} and Andre Terzic and Chronos, {Nicolas A.} and Henry, {Timothy D.} and Peters, {Nicholas S.} and Francisco Fern{\'a}ndez-Avil{\'e}s and Magdi Yacoub and Sanborn, {Timothy A.} and Anthony DeMaria and Schatz, {Richard A.} and Taylor, {Doris A.} and Shmuel Fuchs and Silviu Itescu and Miller, {Leslie W.} and Dinsmore, {Jonathan H.} and Dangas, {George D.} and Popma, {Jeffrey J.} and Hall, {Jennifer L.} and Holmes, {David R.}",

note = "Funding Information: Dr. Dib has received research grants from Cardiovascular Biotherapeutics and Angioblast Systems, Inc. ; and consultant fees from Biologics Delivery Systems, Inc. (Cordis Corporation), and Cardio3 Biosciences. Dr. Bartunek has received research grants from Cardio3 Biosciences . Dr. Zeiher is an advisor and co-founder of t2Cure. Dr. Peters has received research grants from CardioPolymers Inc. and Medtronic, Inc. ; is a consultant and honorarium recipient from CardioPolymers Inc., Ablation Frontiers Inc., AstraZeneca Inc., Sanofi Aventis Inc., Magnetecs Inc., Bard Inc., and Bioheart Inc.; and has intellectual property and stock in CardioPolymers Inc. Dr. Sanborn is on the Speakers' Bureau of Merck; and is a Chairman and on the Data Safety Monitoring Board of St. Jude Medical. Dr. DeMaria has received research grants from Lantheus , Acusphere , CV Therapeutics , Cardiovascular Biotherapeutics , Angioblast Systems, Inc. , Philips Medical Systems , and General Electric Medical Systems ; and has stock options in Cardionet. Dr. Schatz has a licensing agreement with Biologics Delivery Systems and Cordis Corporation; is on the Scientific Advisory Board and Data Safety Monitoring Board of Baxter; and is a Speaker for Cordis Corporation and Medtronic, Inc. Dr. Itescu is President and founder of Angioblast Systems, Inc. Dr. Miller has received a research grant from Thoratec Corp . Dr. Dangas is a consultant for and has received honoraria from Cordis Corporation; and is a speaker for Cordis Corporation, Medtronic, Inc, and Boston Scientific. Dr. Popma has received research grants from Abbott Vascular , Boston Scientific , Cordis , ev3 , and Medtronic, Inc. Dr. Hall is a consultant for Catholic Healthcare West; and has received grants NIH - R01HL081715A1 and NIH - 1R21DK078029-01 . ",

year = "2010",

month = mar,

doi = "10.1016/j.jcin.2009.12.013",

language = "English (US)",

volume = "3",

pages = "265--275",

journal = "JACC: Cardiovascular Interventions",

issn = "1936-8798",

publisher = "Elsevier Inc.",

number = "3",

}

TY - JOUR

T1 - Recommendations for Successful Training on Methods of Delivery of Biologics for Cardiac Regeneration. A Report of the International Society for Cardiovascular Translational Research

AU - Dib, Nabil

AU - Menasche, Philippe

AU - Bartunek, Jozef J.

AU - Zeiher, Andreas M.

AU - Terzic, Andre

AU - Chronos, Nicolas A.

AU - Henry, Timothy D.

AU - Peters, Nicholas S.

AU - Fernández-Avilés, Francisco

AU - Yacoub, Magdi

AU - Sanborn, Timothy A.

AU - DeMaria, Anthony

AU - Schatz, Richard A.

AU - Taylor, Doris A.

AU - Fuchs, Shmuel

AU - Itescu, Silviu

AU - Miller, Leslie W.

AU - Dinsmore, Jonathan H.

AU - Dangas, George D.

AU - Popma, Jeffrey J.

AU - Hall, Jennifer L.

AU - Holmes, David R.

N1 - Funding Information: Dr. Dib has received research grants from Cardiovascular Biotherapeutics and Angioblast Systems, Inc. ; and consultant fees from Biologics Delivery Systems, Inc. (Cordis Corporation), and Cardio3 Biosciences. Dr. Bartunek has received research grants from Cardio3 Biosciences . Dr. Zeiher is an advisor and co-founder of t2Cure. Dr. Peters has received research grants from CardioPolymers Inc. and Medtronic, Inc. ; is a consultant and honorarium recipient from CardioPolymers Inc., Ablation Frontiers Inc., AstraZeneca Inc., Sanofi Aventis Inc., Magnetecs Inc., Bard Inc., and Bioheart Inc.; and has intellectual property and stock in CardioPolymers Inc. Dr. Sanborn is on the Speakers' Bureau of Merck; and is a Chairman and on the Data Safety Monitoring Board of St. Jude Medical. Dr. DeMaria has received research grants from Lantheus , Acusphere , CV Therapeutics , Cardiovascular Biotherapeutics , Angioblast Systems, Inc. , Philips Medical Systems , and General Electric Medical Systems ; and has stock options in Cardionet. Dr. Schatz has a licensing agreement with Biologics Delivery Systems and Cordis Corporation; is on the Scientific Advisory Board and Data Safety Monitoring Board of Baxter; and is a Speaker for Cordis Corporation and Medtronic, Inc. Dr. Itescu is President and founder of Angioblast Systems, Inc. Dr. Miller has received a research grant from Thoratec Corp . Dr. Dangas is a consultant for and has received honoraria from Cordis Corporation; and is a speaker for Cordis Corporation, Medtronic, Inc, and Boston Scientific. Dr. Popma has received research grants from Abbott Vascular , Boston Scientific , Cordis , ev3 , and Medtronic, Inc. Dr. Hall is a consultant for Catholic Healthcare West; and has received grants NIH - R01HL081715A1 and NIH - 1R21DK078029-01 .

PY - 2010/3

Y1 - 2010/3

N2 - The field of myocardial regeneration (angiogenesis and myogenesis) might prove to play an important role in the future management of cardiovascular disease. Stem cells are currently undergoing testing in Phase I and Phase II clinical trials. Methods of delivery will affect the outcome of such therapies, perhaps significantly. This document provides suggested guidance in 4 methods of delivery: endocardial, intracoronary, coronary sinus, and epicardial.

AB - The field of myocardial regeneration (angiogenesis and myogenesis) might prove to play an important role in the future management of cardiovascular disease. Stem cells are currently undergoing testing in Phase I and Phase II clinical trials. Methods of delivery will affect the outcome of such therapies, perhaps significantly. This document provides suggested guidance in 4 methods of delivery: endocardial, intracoronary, coronary sinus, and epicardial.

KW - catheter

KW - injection

KW - myocardial regeneration

KW - stem cells

KW - training

UR - http://www.scopus.com/inward/record.url?scp=77949340085&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77949340085&partnerID=8YFLogxK

U2 - 10.1016/j.jcin.2009.12.013

DO - 10.1016/j.jcin.2009.12.013

M3 - Review article

C2 - 20298983

AN - SCOPUS:77949340085

SN - 1936-8798

VL - 3

SP - 265

EP - 275

JO - JACC: Cardiovascular Interventions

JF - JACC: Cardiovascular Interventions

IS - 3

ER -

Recommendations for Successful Training on Methods of Delivery of Biologics for Cardiac Regeneration. A Report of the International Society for Cardiovascular Translational Research

Abstract

Bibliographical note

Keywords

UN SDGs

Access

OpenUrl availability

Other files and links

Fingerprint

Cite this